AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 216 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $748,000 | -1.8% | 26,458 | -23.0% | 0.05% | +24.3% |
| Q2 2022 | $762,000 | +24.9% | 34,365 | +64.0% | 0.04% | +8.8% |
| Q1 2022 | $610,000 | -35.9% | 20,954 | -27.6% | 0.03% | -2.9% |
| Q4 2021 | $951,000 | +23.2% | 28,931 | +73.0% | 0.04% | -12.5% |
| Q3 2021 | $772,000 | -15.6% | 16,724 | +0.8% | 0.04% | +2.6% |
| Q2 2021 | $915,000 | +286.1% | 16,597 | +204.0% | 0.04% | +95.0% |
| Q4 2020 | $237,000 | -49.1% | 5,460 | -58.9% | 0.02% | -60.8% |
| Q3 2020 | $466,000 | +31.6% | 13,300 | +101.0% | 0.05% | -13.6% |
| Q2 2020 | $354,000 | +26.4% | 6,617 | +12.8% | 0.06% | +156.5% |
| Q4 2019 | $280,000 | -67.9% | 5,865 | -66.5% | 0.02% | -69.7% |
| Q2 2019 | $873,000 | – | 17,510 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |